Question 1

Does CIBC Bancorp USA own IOVA stock?

Accepted Answer

Yes. As of its Q2 2026 13F, CIBC Bancorp USA holds 22,044 shares of IOVA (Iovance Biotherapeutics), worth $91,704.

Question 2

How many shares of IOVA does CIBC Bancorp USA own?

Accepted Answer

As of its Q2 2026 13F, CIBC Bancorp USA holds 22,044 shares of IOVA (Iovance Biotherapeutics).

Question 3

What is CIBC Bancorp USA's IOVA position worth?

Accepted Answer

As of its Q2 2026 13F, CIBC Bancorp USA's IOVA position is worth $91,704.

Question 4

Is CIBC Bancorp USA buying or selling IOVA?

Accepted Answer

In Q2 2026, CIBC Bancorp USA increased its IOVA position by 5,056 shares (+29.8%).

Question 5

When did CIBC Bancorp USA first buy IOVA?

Accepted Answer

CIBC Bancorp USA already held IOVA in its Q3 2025 13F, the earliest on record, and has listed it in 3 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	22,044	+29.8%	$91,704	0.0%	$4.16	27
2026-Q1	Decreased	16,988	-39.0%	$59,628	0.0%	$3.51	0
2025-Q3	First report	27,834	—	$60,400	0.0%	$2.17	0